These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4202492)

  • 1. [Effect of raubasine and dihydroergocristine on arteriosclerotic and hypertensive cerebral diseases].
    Klein K
    Vasa; 1973; 2(4):409-14. PubMed ID: 4202492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of redergam on the cerebral circulation of patients who have suffered insults].
    Khadzhiev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
    Henriet M; Jacquy J; Noel G
    Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical aspects on the therapy of cerebral sclerosis].
    Hoffmeister K
    Med Klin; 1967 Jun; 62(23):910-2. PubMed ID: 4970034
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H
    Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
    [No Abstract]   [Full Text] [Related]  

  • 7. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the behavior of cerebrovascular resistance under the influence of sympatholytics].
    Klein K; Siedek H
    Wien Med Wochenschr; 1966 Jan; 116(1):20-2. PubMed ID: 4962461
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with the vascular action of dihydroergocristine].
    Tomasi AM; Baggioni GF; Pozzar C
    Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sympatholytic vasodilator in cerebral circulation disorders].
    Lipke PR
    Hospital (Rio J); 1969 Dec; 76(6):2159-65. PubMed ID: 4984915
    [No Abstract]   [Full Text] [Related]  

  • 11. [Headaches in patients with vascular deficiency and their treatment with a raubasine-dihydroergocristine association].
    Henry P
    Bord Med; 1972 Nov; 5(18):2531-4. PubMed ID: 4196611
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 13. [Raubasine in combination with ergot alkaloid derivatives in the therapy of closed injuries of the brain].
    Stoppani L
    Arch Sci Med (Torino); 1965 Nov; 120(5):431-9. PubMed ID: 4956319
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydergine for cerebral arteriosclerosis.
    Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of Iskedyl in otoneurologic ischemia].
    Duchamps B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):649-53. PubMed ID: 4280429
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of the cerebral circulation time influenced by hydergine].
    Herzfeld U; Wittgen M
    Arztl Forsch; 1971 Jul; 25(7):224-30. PubMed ID: 4998670
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with gerontotherapeutic agent Wallerox (GN 468)].
    Voegt H; Haid E
    Med Klin; 1970 Nov; 65(46):2031-5. PubMed ID: 5000077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.